收藏切换
A comparative study on the efficacy of faricimab and ranibizumab in treating severe non-proliferative diabetic retinopathy complicated with diabetic macular edema
收藏切换
Lili CHENG1, 2, Jie GAO2, Tao WANG2, *
World Clinical Drug | 2026, 47(3) : 286 - 292
Less
收藏切换
World Clinical Drug | 2026, 47(3): 286-292
• Article •
A comparative study on the efficacy of faricimab and ranibizumab in treating severe non-proliferative diabetic retinopathy complicated with diabetic macular edema
Full
Lili CHENG1, 2, Jie GAO2, Tao WANG2, *
Affiliations
  • 1.Graduate Training Base of Jinzhou Medical University, Jinzhou 121001, Liaoning Province, China
  • 2.Department of Ophthalmology, Linyi People's Hospital, Linyi 276000, Shandong Province, China
Published: 2026-03-10 doi: 10.13683/j.wph.2026.03.009
Outline
收藏切换
Objective

To compare the efficacy of faricimab and ranibizumab in the treatment of severe non-proliferative diabetic retinopathy(NPDR) with diabetic macular edema(DME), and their effects on inflammatory cytokines and visual acuity.

Methods

Eighty patients with severe NPDR complicated with DME from Linyi People's Hospital were selected and randomly divided into the observation group and the control group by simple random sorting method, with 40 cases in each group. The observation group was treated with faricimab, while the control group was treated with ranibizumab.The efficacy, central retinal thickness(CRT), best corrected visual acuity(BCVA), intraocular pressure, inflammatory factors[high-sensitivity C reactive protein(hs-CRP), interleukin(IL)-6, IL-8, tumor necrosis factor(TNF)-α], serum indicators[angiopoietin(Ang)-2, vascular endothelial growth factor(VEGF), intercellular adhesion molecule(ICAM)-1, connective tissue growth factor(CTGF)] and the occurrence of adverse events were compared between the two groups.

Results

After treatment, the efficacy of the observation group was better than that of the control group(P<0.05). After treatment, both groups had an increase in BCVA compared with before treatment(P<0.05). CRT, intraocular pressure, hs-CRP, IL-6, TNF-α, IL-8, Ang-2, VEGF, ICAM-1, CTGF were all decreased compared with before treatment(P<0.05), and the change in the observation group was greater than that in the control group(P<0.05). There was no significant difference in the occurrence of complications between the two groups(P>0.05).

Conclusion

Faricimab is more effective than ranibizumab in the treatment of patients with severe NPDR combined with DME, which can effectively improve visual acuity, reduce inflammation, and improve the levels of VEGF, CTGF, etc., with a favorable safety profile.

faricimab  /  ranibizumab  /  non-proliferative diabetic retinopathy  /  macular edema  /  central retinal thickness  /  vascular endothelial growth factor
程丽丽, 高杰, 王涛. 法瑞西单抗与雷珠单抗对重度非增殖性糖尿病视网膜病变合并糖尿病性黄斑水肿疗效比较研究. 世界临床药物, 2026 , 47 (3) : 286 -292 . DOI: 10.13683/j.wph.2026.03.009
Lili CHENG, Jie GAO, Tao WANG. A comparative study on the efficacy of faricimab and ranibizumab in treating severe non-proliferative diabetic retinopathy complicated with diabetic macular edema[J]. World Clinical Drug, 2026 , 47 (3) : 286 -292 . DOI: 10.13683/j.wph.2026.03.009
Year 2026 volume 47 Issue 3
53
9
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2026.03.009
  • Receive Date:2024-12-28
  • Online Date:2026-11-05
  • Published:2026-03-10
Article Data
Affiliations
History
  • Received:2024-12-28
Funding
Affiliations
    1.Graduate Training Base of Jinzhou Medical University, Jinzhou 121001, Liaoning Province, China
    2.Department of Ophthalmology, Linyi People's Hospital, Linyi 276000, Shandong Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.03.009
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT